High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin

Nephrology Dialysis Transplantation

Volumn 19, Issue 7, 2004, Pages 1890-1894

  Worm, Harald C ^a   Wirnsberger, Gerhard H ^a   Mauric, Astrid ^a   Holzer, Herwig ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Cyclosporin A; Gingival overgrowth; Renal transplantation

Indexed keywords

AZITHROMYCIN; CYCLOSPORIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISONE;

ADULT; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GINGIVA OVERGROWTH; GINGIVECTOMY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYCLOSPORINE; FEMALE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PREVALENCE; TIME FACTORS; TREATMENT FAILURE;

EID: 3242710285     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh095     Document Type: Article

References (24)

1. Pernu HE, Pernu LM, Knuuttila ML, Huttunen KR. Gingival overgrowth among renal transplant recipients and uraemic patients. Nephrol Dial Transplant 1993; 8: 1254-1258
2. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993; 30: 37-40
3. Wirnsberger GH, Pfragner R, Mauric A, Zach R, Bogiatzis A, Holzer H. Effect of antibiotic treatment with azithromycin on cyclosporine A-induced gingival hyperplasia among renal transplant recipients. Transplant Proc 1998; 30: 2117-2119
4. Nash MM, Zaltzman JS. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 1998; 65: 1611
5. Gomez E, Sanchez-Nunez M, Sanchez JE et al. Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 1997; 12: 2694
6. Puig JM, Lloveras J, Bosch JM et al. Treatment of gingival hyperplasia secondary to cyclosporine by the new macrolide azithromycin. Transplant Proc 1997; 29: 2379
7. Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 277
8. Schumacher A, Lerkerød AB, Seljeflot I et al. Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol 2001; 39: 1859-1864
9. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102-106
10. Campbell LA, Perez Melgosa M, Hamilton DJ, Kuo CC, Grayston JT. Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 1992; 30: 434-439
11. Gaydos CA, Summersgill JT, Sahaney NN et al. Replication of Chlamydia pneumoniae in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996; 64: 1614-1620
12. Haralambieva I, Iankov I, Mitev V, Mitov I. KN-62 enhances Chlamydia pneumoniae-induced p44/p42 mitogen-activated protein kinase activation in murine fibroblasts and attenuates in vitro infection. FEMS Microbiol Lett 2002; 215: 149-155
13. Jackson LA, Campbell LA, Schmidt RA et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol 1997; 150: 1785-1790
14. Maraha B, Berg H, Scheffer GJ et al. Correlation between detection methods of Chlamydia pneumoniae in atherosclerotic and non-atherosclerotic tissues. Diagn Microbiol Infect Dis 2001; 39: 139-143
15. Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H. The role of IFN-γ in the outcome of chlamydial infection. Curr Opin Immunol 2002; 14: 444-451
16. Williamson MS, Miller EK, Plemons J, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 1994; 65: 895-903
17. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1 beta and interleukin-6 expression in gingiva: implications for gingival overgrowth. J Periodontol 1999; 70: 294-300
18. Atilla G, Kutukculer N. Cervicular fluid interleukin-1β, tumor necrosis factor-alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A. J Periodontol 1998; 69: 784-790
19. Saikku P, Leinonen M, Mattila KJ et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii: 983-986
20. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998; 29: 404-410
21. Cook PJ, Lip GY, Davies P, Beevers DG, Wise R, Honeybourne D. Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 1998; 31: 589-594
22. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. J Am Med Assoc 1991; 266: 225-230
23. Zocalli C, Mallamaci F, Tripepi G. Atherosclerosis in dialysis patients: does Chlamydia pneumoniae infection contribute to cardiovascular damage? Nephrol Dial Transplant 2002; 17 [Suppl 8]: 25-28
24. Haubitz M, Brunkhorst R. C-reactive protein and chronic Chlamydia pneumoniae infection - long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 809-815